Your browser doesn't support javascript.
loading
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai, Vinodh; Muralidharan, Kavitha; Meng, Wenzhao; Bagashev, Asen; Oldridge, Derek A; Rosenthal, Jaclyn; Van Arnam, John; Melenhorst, Jos J; Mohan, Diwakar; DiNofia, Amanda M; Luo, Minjie; Cherian, Sindhu; Fromm, Jonathan R; Wertheim, Gerald; Thomas-Tikhonenko, Andrei; Paessler, Michele; June, Carl H; Luning Prak, Eline T; Bhoj, Vijay G; Grupp, Stephan A; Maude, Shannon L; Rheingold, Susan R.
Afiliación
  • Pillai V; Department of Pathology and Laboratory Medicine and.
  • Muralidharan K; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Meng W; Department of Pathology and Laboratory Medicine and.
  • Bagashev A; Department of Pathology and Laboratory Medicine and.
  • Oldridge DA; Department of Pathology and Laboratory Medicine and.
  • Rosenthal J; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Van Arnam J; Department of Pathology and Laboratory Medicine and.
  • Melenhorst JJ; Department of Pathology and Laboratory Medicine and.
  • Mohan D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • DiNofia AM; Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and.
  • Luo M; Department of Pathology and Laboratory Medicine and.
  • Cherian S; Department of Laboratory Medicine, University of Washington, Seattle, WA.
  • Fromm JR; Department of Laboratory Medicine, University of Washington, Seattle, WA.
  • Wertheim G; Department of Pathology and Laboratory Medicine and.
  • Thomas-Tikhonenko A; Department of Pathology and Laboratory Medicine and.
  • Paessler M; Department of Pathology and Laboratory Medicine and.
  • June CH; Department of Pathology and Laboratory Medicine and.
  • Luning Prak ET; Department of Pathology and Laboratory Medicine and.
  • Bhoj VG; Department of Pathology and Laboratory Medicine and.
  • Grupp SA; Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and.
  • Maude SL; Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and.
  • Rheingold SR; Division of Oncology, Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA; and.
Blood Adv ; 3(22): 3539-3549, 2019 11 26.
Article en En | MEDLINE | ID: mdl-31738832
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos